Clinical Trials at the University of Kansas Medical Center

The following industry sponsored clinical trials are currently being carried out by members of the Liver Center at the University of Kansas Medical Center:

Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients
Diagnosed With Hepatocellular Carcinoma

A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib (GIDEON)

For more information on clinical trials at KUMC, you may contact Scott Stanley in the division of Gastroenterology.